Burkitt lymphoma and Hypersensitivity

Summary:

Hypersensitivity is found among people with Burkitt lymphoma, especially for people who are male, 50-59 old.

The study analyzes which people have Hypersensitivity with Burkitt lymphoma. It is created by eHealthMe based on reports of 185 people who have Burkitt lymphoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Burkitt lymphoma?

Burkitt lymphoma (cancer of the lymphatic system) is found to be associated with 374 drugs and 812 conditions by eHealthMe. Check the latest studies of Burkitt lymphoma.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,751 drugs and 2,915 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

185 people who have Burkitt Lymphoma and Hypersensitivity are studied.

Would you have Hypersensitivity when you have Burkitt lymphoma?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Burkitt lymphoma (28,141 reports)
Hypersensitivity (272,618 reports)

All the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,751 drugs)

All the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,915 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypersensitivity and Burkitt lymphoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.